191 related articles for article (PubMed ID: 31383926)
1. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Berroterán-Infante N; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hartmann AM; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Mol Psychiatry; 2021 Mar; 26(3):1009-1018. PubMed ID: 31383926
[TBL] [Abstract][Full Text] [Related]
2. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
[TBL] [Abstract][Full Text] [Related]
3. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
[TBL] [Abstract][Full Text] [Related]
4. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[
Ulke C; Rullmann M; Huang J; Luthardt J; Becker GA; Patt M; Meyer PM; Tiepolt S; Hesse S; Sabri O; Strauß M
Transl Psychiatry; 2019 Nov; 9(1):301. PubMed ID: 31732713
[TBL] [Abstract][Full Text] [Related]
5. PET Quantification of the Norepinephrine Transporter in Human Brain with (
Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
8. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
[TBL] [Abstract][Full Text] [Related]
9. [18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.
Rami-Mark C; Zhang MR; Mitterhauser M; Lanzenberger R; Hacker M; Wadsak W
Nucl Med Biol; 2013 Nov; 40(8):1049-54. PubMed ID: 24100201
[TBL] [Abstract][Full Text] [Related]
10. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
Neurochem Int; 2010; 56(6-7):789-98. PubMed ID: 20211213
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
[TBL] [Abstract][Full Text] [Related]
12. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
[TBL] [Abstract][Full Text] [Related]
13. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
[TBL] [Abstract][Full Text] [Related]
14. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
Hahn MK; Steele A; Couch RS; Stein MA; Krueger JJ
Neuropharmacology; 2009 Dec; 57(7-8):694-701. PubMed ID: 19698724
[TBL] [Abstract][Full Text] [Related]
15. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide DNA Methylation Patterns in Persistent Attention-Deficit/Hyperactivity Disorder and in Association With Impulsive and Callous Traits.
Meijer M; Klein M; Hannon E; van der Meer D; Hartman C; Oosterlaan J; Heslenfeld D; Hoekstra PJ; Buitelaar J; Mill J; Franke B
Front Genet; 2020; 11():16. PubMed ID: 32082368
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.
Wiers CE; Lohoff FW; Lee J; Muench C; Freeman C; Zehra A; Marenco S; Lipska BK; Auluck PK; Feng N; Sun H; Goldman D; Swanson JM; Wang GJ; Volkow ND
Eur J Neurosci; 2018 Aug; 48(3):1884-1895. PubMed ID: 30033547
[TBL] [Abstract][Full Text] [Related]
18. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
Kim JW; Biederman J; McGrath CL; Doyle AE; Mick E; Fagerness J; Purcell S; Smoller JW; Sklar P; Faraone SV
Mol Psychiatry; 2008 Jun; 13(6):624-30. PubMed ID: 17876324
[TBL] [Abstract][Full Text] [Related]
19. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.
Kim CH; Waldman ID; Blakely RD; Kim KS
Ann N Y Acad Sci; 2008; 1129():256-60. PubMed ID: 18591486
[TBL] [Abstract][Full Text] [Related]
20. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
